Stock Analiz

Corvus Pharmaceuticals, Inc. (CRVS) stock forecast and price target

Price $10.64 · data as of November 13, 2026

12-month price target

Average target$31.50
Upside / downside+196.1%
Analysts6
ConsensusStrong buy
Low $27.00Average $31.50High $42.00

Gold marker: average target · white marker: today’s price ($10.64)

Analyst ratings

Strong buy 1Buy 5Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.80−49.4%$0
Next fiscal year
ends December 31, 2027
$-1.10−37.1%$2M
Next quarter
ends December 31, 2026
$-0.23−56.7%$0
Quarter after
ends March 31, 2027
$-0.27−80.0%$0

Consensus of the analysts covering Corvus Pharmaceuticals, updated daily. In the last 30 days 0 estimates were raised and 1 lowered.

Frequently asked questions

What is the Corvus Pharmaceuticals stock price target?

The average 12-month target from 6 analysts is $31.50, 196.1% above the current price of $10.64 Targets range from $27.00 to $42.00.

Is Corvus Pharmaceuticals a buy according to analysts?

The consensus rating is “Strong buy” (1 strong buy, 5 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Corvus Pharmaceuticals expected to earn?

Analysts expect EPS of $-0.80 for the fiscal year ending December 31, 2026 and $-1.10 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.